001     163175
005     20240229123150.0
024 7 _ |a 10.1093/eurpub/ckaa053
|2 doi
024 7 _ |a pmid:32918815
|2 pmid
024 7 _ |a 1101-1262
|2 ISSN
024 7 _ |a 1464-360X
|2 ISSN
024 7 _ |a altmetric:90480642
|2 altmetric
037 _ _ |a DKFZ-2020-01878
041 _ _ |a eng
082 _ _ |a 610
100 1 _ |a Aleyan, Sarah
|b 0
245 _ _ |a Evaluating the impact of introducing standardized packaging with larger health-warning labels in England: findings from adult smokers within the EUREST-PLUS ITC Europe Surveys.
260 _ _ |a Oxford [u.a.]
|c 2020
|b Oxford Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1600257507_11501
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The European (EU) Tobacco Product Directive (TPD) was implemented in May 2016 to regulate the design and labelling of cigarettes and roll-your-own tobacco. At the same time, the UK introduced standardized packaging measures, whereas Germany, Greece, Hungary, Poland, Romania and Spain did not. This study examines the impact of introducing standardized packaging in England using a quasi-experimental design.Data from adult smokers in Waves 1 (2016; N=9547) and 2 (2018; N=9724) from the International Tobacco Control Policy Evaluation surveys (England) and EUREST-PLUS surveys (Germany, Greece, Hungary, Poland, Romania and Spain) were used. Generalized estimating equations were used to estimate changes in pack/brand appeal, salience of health-warning labels (HWLs) and perceived relative harm of different brands in England (where larger HWLs and standardized packaging were implemented), vs. each EU country (where only larger HWLs were implemented).There was an increase in the percentage of respondents from Germany, Hungary and Poland reporting they did not like the look of the pack (4.7%, 9.6%, and 14.2%, respectively), but the largest increase was in England (41.0%). Moreover, there was a statistically significant increase in the salience of HWLs in Hungary, Poland and Romania (17.0%, 13.9%, and 15.3%, respectively), but the largest increase was in England (27.6%). Few differences were observed in cross-country comparisons of the perceived relative harm of different brands.Findings suggest that standardized packaging reduces pack appeal and enhances the salience of HWLs over and above the effects of larger HWLs. Findings provide additional evidence and support for incorporating standardized packaging into the EU TPD.
536 _ _ |a 319H - Addenda (POF3-319H)
|0 G:(DE-HGF)POF3-319H
|c POF3-319H
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Driezen, Pete
|b 1
700 1 _ |a McNeill, Ann
|b 2
700 1 _ |a McDermott, Máirtín
|b 3
700 1 _ |a Kahnert, Sarah
|0 P:(DE-He78)31e693b68321c8926e1f6e78f60b5505
|b 4
|u dkfz
700 1 _ |a Kyriakos, Christina N
|b 5
700 1 _ |a Mons, Ute
|0 P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9
|b 6
|u dkfz
700 1 _ |a Fernández, Esteve
|b 7
700 1 _ |a Trofor, Antigona C
|b 8
700 1 _ |a Zatoński, Mateusz
|b 9
700 1 _ |a Demjén, Tibor
|b 10
700 1 _ |a Katsaounou, Paraskevi A
|b 11
700 1 _ |a Przewoźniak, Krzysztof
|b 12
700 1 _ |a Balmford, James
|b 13
700 1 _ |a Filippidis, Filippos T
|b 14
700 1 _ |a Fong, Geoffrey T
|b 15
700 1 _ |a Vardavas, Constantine I
|b 16
700 1 _ |a Hitchman, Sara C
|b 17
700 1 _ |a Consortium, EUREST-PLUS
|b 18
|e Collaboration Author
700 1 _ |a Vardavas, Constantine I
|b 19
700 1 _ |a Glahn, Andrea
|b 20
700 1 _ |a Kyriakos, Christina N
|b 21
700 1 _ |a Nguyen, Dominick
|b 22
700 1 _ |a Nikitara, Katerina
|b 23
700 1 _ |a Radu-Loghin, Cornel
|b 24
700 1 _ |a Starchenko, Polina
|b 25
700 1 _ |a Tsatsakis, Aristidis
|b 26
700 1 _ |a Girvalaki, Charis
|b 27
700 1 _ |a Igoumenaki, Chryssi
|b 28
700 1 _ |a Papadakis, Sophia
|b 29
700 1 _ |a Papathanasaki, Aikaterini
|b 30
700 1 _ |a Tzatzarakis, Manolis
|b 31
700 1 _ |a Vardavas, Alexander I
|b 32
700 1 _ |a Bécuwe, Nicolas
|b 33
700 1 _ |a Deaconu, Lavinia
|b 34
700 1 _ |a Goudet, Sophie
|b 35
700 1 _ |a Hanley, Christopher
|b 36
700 1 _ |a Rivière, Oscar
|b 37
700 1 _ |a Demjén, Tibor
|b 38
700 1 _ |a Kiss, Judit
|b 39
700 1 _ |a Kovacs, Anna Piroska
|b 40
700 1 _ |a Fernández, Esteve
|b 41
700 1 _ |a Castellano, Yolanda
|b 42
700 1 _ |a Fu, Marcela
|b 43
700 1 _ |a Nogueira, Sarah O
|b 44
700 1 _ |a Tigova, Olena
|b 45
700 1 _ |a McNeill, Ann
|b 46
700 1 _ |a East, Katherine
|b 47
700 1 _ |a Hitchman, Sara C
|b 48
700 1 _ |a McDermott, Máirtín
|b 49
700 1 _ |a Aleyan, Sarah
|b 50
700 1 _ |a Mons, Ute
|0 P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9
|b 51
|u dkfz
700 1 _ |a Kahnert, Sarah
|0 P:(DE-He78)31e693b68321c8926e1f6e78f60b5505
|b 52
|u dkfz
700 1 _ |a Tountas, Yannis
|b 53
700 1 _ |a Behrakis, Panagiotis
|b 54
700 1 _ |a Filippidis, Filippos T
|b 55
700 1 _ |a Gratziou, Christina
|b 56
700 1 _ |a Katsaounou, Paraskevi
|b 57
700 1 _ |a Peleki, Theodosia
|b 58
700 1 _ |a Petroulia, Ioanna
|b 59
700 1 _ |a Tzavara, Chara
|b 60
700 1 _ |a Trofor, Antigona Carmen
|b 61
700 1 _ |a Eremia, Marius
|b 62
700 1 _ |a Lotrean, Lucia
|b 63
700 1 _ |a Mihaltan, Florin
|b 64
700 1 _ |a Rohde, Gernot
|b 65
700 1 _ |a Asano, Tamaki
|b 66
700 1 _ |a Cichon, Claudia
|b 67
700 1 _ |a Far, Amy
|b 68
700 1 _ |a Genton, Céline
|b 69
700 1 _ |a Jessner, Melanie
|b 70
700 1 _ |a Hedman, Linnea
|b 71
700 1 _ |a Janson, Christer
|b 72
700 1 _ |a Lindberg, Ann
|b 73
700 1 _ |a Maguire, Beth
|b 74
700 1 _ |a Ravara, Sofia
|b 75
700 1 _ |a Vaccaro, Valérie
|b 76
700 1 _ |a Ward, Brian
|b 77
700 1 _ |a Willemsen, Marc
|b 78
700 1 _ |a de Vries, Hein
|b 79
700 1 _ |a Hummel, Karin
|b 80
700 1 _ |a Nagelhout, Gera E
|b 81
700 1 _ |a Zatoński, Witold A
|b 82
700 1 _ |a Herbeć, Aleksandra
|b 83
700 1 _ |a Janik-Koncewicz, Kinga
|b 84
700 1 _ |a Przewoźniak, Krzysztof
|b 85
700 1 _ |a Zatoński, Mateusz
|b 86
700 1 _ |a Fong, Geoffrey T
|b 87
700 1 _ |a Agar, Thomas K
|b 88
700 1 _ |a Driezen, Pete
|b 89
700 1 _ |a Gravely, Shannon
|b 90
700 1 _ |a Quah, Anne C K
|b 91
700 1 _ |a Thompson, Mary E
|b 92
773 _ _ |a 10.1093/eurpub/ckaa053
|g Vol. 30, no. Supplement_3, p. iii91 - iii97
|0 PERI:(DE-600)2033525-8
|n Supplement_3
|p iii91 - iii97
|t European journal of public health
|v 30
|y 2020
|x 1464-360X
909 C O |o oai:inrepo02.dkfz.de:163175
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-He78)31e693b68321c8926e1f6e78f60b5505
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 51
|6 P:(DE-He78)1b59582b6c05ac4e57aa8b90dd9667f9
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 52
|6 P:(DE-He78)31e693b68321c8926e1f6e78f60b5505
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-319H
|2 G:(DE-HGF)POF3-300
|v Addenda
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2020-01-17
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2020-01-17
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2020-01-17
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0130
|2 StatID
|b Social Sciences Citation Index
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1180
|2 StatID
|b Current Contents - Social and Behavioral Sciences
|d 2020-01-17
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J PUBLIC HEALTH : 2018
|d 2020-01-17
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2020-01-17
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2020-01-17
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2020-01-17
920 1 _ |0 I:(DE-He78)M050-20160331
|k M050
|l M050 Krebsprävention
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)M050-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21